Sarah Slack is a Research Associate in the Sabeti Lab, working to develop CRISPR-Cas13-based antiviral therapies for RNA viruses. Prior to joining the lab, Sarah completed her undergraduate degree in 2020 at the University of Washington with a major in Bioengineering and a minor in Portuguese Language and Luso-Brazilian Studies. During her time there, she conducted research in the Woodrow Lab, primarily working to develop a nanoparticle platform for HIV latency reversal and cure. In the future, Sarah plans to become a physician researcher focusing on international infectious disease, integrating her study of Portuguese, and what she has learned from studying it, into her work.